Arcutis Drug Is with FDA for Approval
Arcutis Debuts Its First ESG Report
Business Events Calendar
Worthe Starts 30-Acre Burbank Project
OpEd: Policy Creates Solar Blind Spot
FloQast Raises $100 Million, Eyes IPO
WeWork Amends Lease in NoHo